BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35362266)

  • 1. Adequacy in pleural effusion: What is the minimum volume required for detection of malignant cells?
    Jha S; Sethy M; Sharma G; Adhya AK
    Diagn Cytopathol; 2022 Jun; 50(6):284-288. PubMed ID: 35362266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessing the optimal volume for malignancy detection in serous fluid cytology.
    Coconubo DM; Baskota SU; Li R; Srivastava P; Cuda J; Khader S
    Cancer Cytopathol; 2022 Jul; 130(7):551-557. PubMed ID: 35468659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number of mesothelial cells as a measure of adequacy criteria for pleural effusions: A multi-institutional study.
    Rodriguez EF; Morris PC; Calsavara V; Pastorello RG; Saieg M
    Cytopathology; 2020 May; 31(3):223-227. PubMed ID: 32048382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic Pleural Effusions: Characteristics and Discrimination From Cytology-Negative Malignant Pleural Effusions.
    Park JE; Do YW; Lee DH; Lee SY; Lim JK; Choi SH; Seo HW; Yoo SS; Lee SY; Cha SI; Park JY; Lee J; Kim CH
    Am J Med Sci; 2020 Sep; 360(3):236-242. PubMed ID: 32423747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases.
    Rooper LM; Ali SZ; Olson MT
    Cancer Cytopathol; 2014 Sep; 122(9):657-65. PubMed ID: 25060164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How much is enough: investigation of pleural fluid cytology findings related to sample volume.
    Torous VF
    J Am Soc Cytopathol; 2022; 11(2):94-101. PubMed ID: 34998728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
    Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
    Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology.
    Rodriguez EF; Pastorello RG; Morris P; Saieg M; Chowsilpa S; Maleki Z
    Am J Clin Pathol; 2020 Aug; 154(3):394-402. PubMed ID: 32525969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimising the utility of pleural fluid adenosine deaminase for the diagnosis of adult tuberculous pleural effusion in Hong Kong.
    Chang KC; Chan MC; Leung WM; Kong FY; Mak CM; Chen SP; Yu WC
    Hong Kong Med J; 2018 Feb; 24(1):38-47. PubMed ID: 29269590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts.
    Yang Q; Niu Y; Wen JX; Yang DN; Han YL; Wen XH; Yan L; Huang JH; Chen H; Zheng WQ; Jiang TW; Hu ZD
    Ther Adv Respir Dis; 2023; 17():17534666231216566. PubMed ID: 38084849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion.
    Abouzgheib W; Bartter T; Dagher H; Pratter M; Klump W
    Chest; 2009 Apr; 135(4):999-1001. PubMed ID: 19017891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
    Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
    Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
    Choi H; Ko Y; Lee CY
    BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema.
    Bishara J; Goldberg E; Ashkenazi S; Yuhas Y; Samra Z; Saute M; Shaked H
    Ann Thorac Surg; 2009 Jan; 87(1):251-4. PubMed ID: 19101307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the pleural fluid transudate or exudate? A revisit of the diagnostic criteria.
    Joseph J; Badrinath P; Basran GS; Sahn SA
    Thorax; 2001 Nov; 56(11):867-70. PubMed ID: 11641512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of CYFRA 21-1 in malignant pleural effusion.
    Dejsomritrutai W; Senawong S; Promkiamon B
    Respirology; 2001 Sep; 6(3):213-6. PubMed ID: 11555379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleural fluid cell-free DNA in parapneumonic pleural effusion.
    Santotoribio JD; Cabrera-Alarcón JL; Batalha-Caetano P; Macher HC; Guerrero JM
    Clin Biochem; 2015 Oct; 48(15):1003-5. PubMed ID: 26234638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.
    Chantharakhit C; Sujaritvanichpong N
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):25-31. PubMed ID: 35092368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.